Table 2.
Repeated measures correlation between density measures in the group of women that did not receive tamoxifen from analysis sample A (all women included in the study)
Visual % | Stratus % | Densitas % | Volpara % | Stratus DA | Densitas DA | Volpara DV | Densitas BA | Volpara TV | |
---|---|---|---|---|---|---|---|---|---|
Stratus % | 0.85 | ||||||||
Densitas % | 0.87 | 0.90 | |||||||
Volpara % | 0.89 | 0.92 | 0.92 | ||||||
Stratus DA | 0.68 | 0.86 | 0.74 | 0.67 | |||||
Densitas DA | 0.12 | 0.14 | 0.18 | −0.02 | 0.57 | ||||
Volpara DV | 0.40 | 0.41 | 0.44 | 0.28 | 0.73 | 0.81 | |||
Densitas BA | −0.45 | −0.48 | −0.51 | −0.62 | −0.03 | 0.74 | 0.42 | ||
Volpara TV | −0.49 | −0.52 | −0.49 | −0.69 | −0.05 | 0.64 | 0.50 | 0.88 | |
NNVAS % | 0.89 | 0.93 | 0.92 | 0.91 | 0.83 | 0.25 | 0.52 | −0.39 | −0.43 |
DA dense area, DV dense volume, BA breast area, TV total volume, NNVAS neural network visual assessment score